Breast cancer prognostic test Digistain available to selected UK private patients with reimbursement from Bupa, WPA and Healix

We’re thrilled to announce that Digistain® is now available to selected UK private patients, with reimbursement available though Bupa, WPA Health Insurance & Healix.

Tim Woodman, Medical Director at Bupa’s Policy and Cancer Services, said:

“I’m really excited to be working with Digistain.”